Status:
RECRUITING
Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients
Lead Sponsor:
University of California, Los Angeles
Conditions:
Ophthalmic Disease
Artifical Intelligence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial is testing whether plain language summaries made by artificial intelligence help people understand their eye doctor's notes better. Adults receiving eye care at the Jules Stein Eye...
Detailed Description
This study employs a two-arm randomized controlled trial to evaluate whether artificial intelligence (AI)-generated plain language summaries (PLSs) can improve patient comprehension of ophthalmology n...
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years English-speaking Receiving ophthalmology care at the Jules Stein Eye Institute Able to provide informed consent
Exclusion Criteria:
- Known cognitive impairments (e.g., dementia, intellectual disability) that would affect comprehension Prisoners or wards of the state Unable to provide informed consent
Key Trial Info
Start Date :
March 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT06859216
Start Date
March 1 2025
End Date
June 1 2026
Last Update
March 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095